Self-Affirmation and Response to Health Risk Information
|ClinicalTrials.gov Identifier: NCT01668771|
Recruitment Status : Completed
First Posted : August 20, 2012
Last Update Posted : July 2, 2017
- Self-affirmation is the process of reflecting on values that a person considers important. This process may encourage people to be more open to information about health risks. It may also encourage them to change their behaviors or lifestyle to decrease these health risks. Researchers want to look at the effect of self-affirmation on people s responses to new health risk information. Because recent studies have linked alcohol consumption to increased risk of breast cancer, the study will focus on alcohol s link to breast cancer.
- To study how self-affirmation can change opinions following a message about a health risk.
- Women at least 18 years of age who drink at least two alcoholic beverages per week and/or at least three alcoholic beverages per sitting.
- Participants will be recruited through an online panel. The study will be conducted entirely online.
- Participants will respond to two short studies. The first will ask about life events and how they make people feel. The second will look at how people respond to information about alcohol and breast cancer.
- For the first study, participants will write a paragraph or two about an important event in their lives. They will answer questions about how that event made them feel. They will also write a paragraph about an important personal value.
- For the second study, participants will read information about alcohol and breast cancer risk. They will then answer questions about this information. They will also answer questions about their beliefs about alcohol and breast cancer.
- Participants will receive financial compensation for being in this study.
|Condition or disease|
|Alcohol Drinking Emotions Ego|
|Study Type :||Observational|
|Estimated Enrollment :||1116 participants|
|Official Title:||Self-Affirmation, Affect, and Implementation Intentions for Alcohol Cessation|
|Study Start Date :||August 11, 2012|
|Estimated Study Completion Date :||May 13, 2013|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01668771
|United States, Maryland|
|National Cancer Institute (NCI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Rebecca A Ferrer, Ph.D.||National Cancer Institute (NCI)|